Atlas Trials

Compassionate Use of Pozelimab

Clinical trial NCT05232110 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT05232110
Sponsor
Regeneron Pharmaceuticals
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
CD55-deficient Protein-losing Enteropathy

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.